Among the three members of the SCP family and their primary target, RB1, only CTDSPL demonstrated significant downregulation in ccRCC in most samples (three-fold on average; see Supplementary Table S1). This evidence concerns the gene CTDSPL and nonpapillary renal cell carcinoma.